3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Sponsor Class
OTHER
53
INDUSTRY
19
OTHER_GOV
2
INDIV
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Sarcoma
1
Other hematologic neoplasm
1
Genitourinary
1
Breast
1
Conditions
Cholangiocarcinoma
2
Interventions
Oxaliplatin
30
Capecitabine
26
Fluorouracil
20
Irinotecan
19
tislelizumab
18
apatinib
16
Paclitaxel
13
Cisplatin
13
S 1 (combination)
12
Radiotherapy
12
Leucovorin
11
Bevacizumab
11
Laparoscopy
9
Drug Therapy
9
Cetuximab
9
sintilimab
8
Endoscopic Mucosal Resection
8
Radiation
7
Gemcitabine
7
Docetaxel
7
camrelizumab
6
XELOX
6
Surgical Procedures, Operative
6
Propranolol
6
Nivolumab
6
Neoadjuvant Therapy
6
Immune Checkpoint Inhibitors
6
Folfox protocol
6
Levoleucovorin
5
HMPL-013
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Everolimus
×
Gastrointestinal
×
Clear all
NCT01525719
2012-02-03
CRAD001T
Ratchavithi Hospital
Phase 2
Unknown
40 enrolled
NCT00973713
2009-09-09
RADiChol
Austin Health
Phase 2
Unknown
27 enrolled